Porcine epidemic diarrhea virus (PEDV) is a member of the genus *Alphacoronavirus*, which belongs to the family *Coronaviridae* in the order *Nidovirales*. The genome of this single-stranded, positive-sense RNA virus encodes, from 5′ to 3′, the replicase polyproteins pp1a and pp1b, spike (S) protein, ORF3 accessory protein, envelope (E) protein, membrane (M) protein and nucleocapsid (N) protein[@b1][@b2][@b3]. The typical clinical signs of PEDV infection include watery diarrhea, vomiting, and dehydration. Porcine epidemic diarrhea (PED) was first reported in England in 1971 and then in many other European and Asian countries in the following 30 years. With the advent of live attenuated vaccines, acute outbreaks became rare in both Europe and Asia during 2000--2006[@b4][@b5][@b6][@b7][@b8]. Since 2007, however, PEDV has re-emerged and spread across the globe, reaching Asia (Thailand, Vietnam, Japan, and China), Europe (Germany, Spain, Belgium, France, and Portugal), North America (US, Mexico, and Canada), and Australia. These outbreaks were characterized by high morbidity (80--100%) and mortality (50--90%) among suckling piglets[@b9][@b10][@b11][@b12][@b13][@b14][@b15][@b16][@b17][@b18][@b19][@b20][@b21][@b22][@b23], causing substantial financial losses to the domestic swine industry. The severity of these epidemics emphasizes the importance of establishing effective disease control and prevention systems worldwide[@b24], which will largely depend on well-validated diagnostics tests and vaccinations for PEDV.

The coronavirus N protein binds viral RNA and is involved in several of the biological activities of the virus[@b25][@b26]. Previous studies have shown that PEDV N protein is responsible for viral nucleolar localization, host cycle ER stress, S-phase prolongation, up-regulation of interleukin-8 expression and inhibition of interferon-β production[@b27][@b28][@b29]. In addition, PEDV N protein is highly conserved. Large amounts of PEDV N protein can be detected in virus-infected cells, and abundant antibodies against N protein could be induced at the early stage of PEDV infection[@b30][@b31]. Such features of the N protein make it an ideal target antigen for PEDV diagnosis[@b32], emphasizing the importance of characterizing the epitopes of PEDV N protein and their related MAbs. Previous research on this issue has been scarce. To our knowledge, only one MAb specific to PEDV N protein has been reported so far, with little information regarding its corresponding epitope and whether it could cross-react with TGEV N protein[@b33]. More detailed research aimed at characterizing PEDV N protein epitopes is urgently needed.

Acute diarrhea caused by PEDV is clinically difficult to distinguish from disease caused by transmissible gastroenteritis virus (TGEV). Therefore, PEDV infection cannot be diagnosed on the basis of clinical findings alone, and laboratory tests are necessary for an etiological diagnosis[@b34]. Presently, the most commonly used diagnostic methods are reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR, both of which have a high efficiency and reliability in detecting viral genetic materials in fecal and intestinal samples. In addition, immunofluorescence assays (IFAs), electron microscopy (EM), immunohistochemistry, *in situ* hybridization, enzyme-linked immunosorbent assays (ELISAs), immunochromatography assays and fluorescent microsphere immunoassays (FMIAs) have been widely used to diagnose PEDV infection[@b35][@b36][@b37][@b38][@b39][@b40][@b41][@b42][@b43][@b44][@b45]. Among these methods, ELISA has the greatest potential for clinical diagnosis on a large scale and the greatest significance for the effective detection and control of PEDV, especially in developing countries, where few pig farms are equipped with qualified laboratories for complicated molecular diagnoses. However, the previously established method of indirect ELISA used either the viral proteins extracted from PEDV-infected Vero cells or recombinant N protein generated in *Escherichia coli* as coating antigens; in some documented DAS-ELISA methods, the specificity of the capture and detection antibodies was unclear[@b40][@b41][@b46]. Furthermore, in a recent study, researchers observed the cross-reactivity between PEDV and pig TGEV antisera. They also inferred that one or more epitopes on the N protein could be the contributing factors[@b47]. These findings called into question the accuracy of current ELISA methods. To establish more reliable serodiagnostic methods for PEDV, it is important to generate MAbs that bind only to PEDV N protein and to map which of their corresponding epitopes that can be recognized by PEDV pig antisera alone.

Most proteins carry out biological functions based on their unique and stable three-dimensional structures. However, studies in recent decades have reported an increasing number of proteins that are fully (intrinsically disordered proteins, IDPs) or partially (intrinsically disordered regions, IDRs) unfolded or disordered under normal physiological conditions yet remain active and functional[@b48][@b49][@b50][@b51]. Moreover, the essential roles of IDPs/IDRs in the protein interaction network, including cell signaling, transcription, translation, and the cell cycle, have been confirmed[@b50][@b52][@b53][@b54]. In particular, disorder abundance can be predicted and observed in viral proteins[@b55][@b56]. The unstable structures of IDPs/IDRs make it difficult for the immune system to recognize the viral epitopes, eliciting a poor immune response from the host. Partially or wholly unfolded viral proteins can also quickly adapt to and survive in the host environment due to the very high mutation rates of viral genomes[@b57][@b58]. Moreover, IDPs, as important components of antigens, are abundant in several pathogenic organisms[@b59][@b60]. Disordered epitopes are distinct and specific, and they efficiently interact with their cognate antibodies[@b60][@b61]. Studies have demonstrated that the molecular mechanism by which IDPs function is closely associated with the transition from the disordered to the folded state upon binding with their partners, which could be proteins, DNA, RNA or membranes[@b51][@b62][@b63]. However, a similar phenomenon in terms of the recognition of disordered epitopes by antibodies has not yet been reported. Studies on SARS have demonstrated that IDRs comprise the flexible linker between the N-terminal domain (NTD) and C-terminal domain (CTD) in N protein and have RNA-binding abilities[@b64]. However, little attention has been paid to characterizing other intrinsically disordered epitopes of Coronaviruses.

To better understand the characterization of epitopes on PEDV N protein, in this study, two MAbs against N protein (PN-D4 and PN-D6) were generated, and their corresponding epitopes (NEP-D4 and NEP-D6) were identified and characterized. Further analysis based on sequence alignment, IFA and Western blotting showed the conservation, specificity and immunogenicity of NEP-D4 and NEP-D6. We also demonstrated that both NEP-D4 and NEP-D6 failed to result in cross-reactivity between PEDV and TGEV. Thus, these two MAbs (PN-D4 and PN-D6) and their corresponding epitopes (NEP-D4 and NEP-D6) could be theoretically applied to clinically accessible diagnostic assays for PEDV. In addition, GeneSilico metadisorder and Phyre2 3D structure prediction, freeze-thaw cycle analysis, and treatment with trypsin and DTT all indicated that NEP-D4 is probably an intrinsically disordered protein. Based on these findings, we speculated that the folding following the binding effect might be the factor behind the recognition of NEP-D4 by PN-D4. This finding has not been previously reported but might warrant further investigation aimed at better understanding the mechanism by which a disordered epitope combines with its cognate antibody.

Results
=======

Production and Selection of MAbs against PEDV N protein
-------------------------------------------------------

To generate MAbs specific to the PEDV N protein, we immunized BALB/c mice with the purified PEDV strain FJzz1/2011. We acquired hybridoma cells by fusing SP20 cells and the spleen cells from immunized mice. Next, the hybridoma cell lines that survived culture in HAT and HT media were screened by IFA against the PEDV strain FJzz1/2011. We obtained six positive clones (F21-F3, F31-F3, F31-D4, F31-G4, F31-D6 and F42-G4) that were specific to PEDV ([Fig. 1a](#f1){ref-type="fig"}). We then examined which MAbs could detect the GST-tagged recombinant N protein using indirect ELISA. F31-D4 and F31-D6 exhibited a positive color, whereas F21-F3, F31-F3, F31-G4 and F42-G4 were negative ([Fig. 1b](#f1){ref-type="fig"}). We designated the MAbs secreted by hybridomas F31-D4 and F31-D6 as PN-D4 and PN-D6, respectively. The results suggested that MAbs PN-D4 and PN-D6 are specific to PEDV N protein.

Fine epitope mapping of PEDV N protein
--------------------------------------

To identify the antigenic determinants that could be recognized by MAbs PN-D4 and PN-D6, two mutually overlapping GST-fusion-truncated constructs (GST-N1 and GST-N2) that span the complete N protein were expressed for detection by MAbs using ELISA ([Fig. 2b](#f2){ref-type="fig"} and c). MAb PN-D4 recognized only GST-N1, whereas MAb PN-D6 only recognized GST-N2 ([Fig. 2c](#f2){ref-type="fig"}). To locate the precise positions of the two epitopes, as depicted in [Fig. 2a](#f2){ref-type="fig"}, N1 and N2 were further truncated into two discrete groups of GST-fusion constructs, which were detected by PN-D4 or PN-D6 in ELISA and Western blotting assays. The results in [Fig. 3](#f3){ref-type="fig"} showed that the minimum antigenic epitopes that MAbs PN-D4 and PN-D6 could recognize were N1-10 (residues 18--133) and N2-10 (residues 252--262), respectively, which were designated NEP-D4 and NEP-D6, respectively.

Immunogenicity analysis of the epitopes
---------------------------------------

To determine whether PEDV-infected pigs could produce specific antibodies against NEP-D4 and NEP-D6, we performed Western blotting using anti-PEDV porcine antisera obtained 14 and 21 days after immunization to detect the two GST-fusion peptides. The results showed that both lanes loaded with NEP-D4 or NEP-D6 produced positive bands at the expected molecular masses, indicating that NEP-D4 and NEP-D6 are both immunogenic epitopes of PEDV.

The epitopes are highly conserved and specific
----------------------------------------------

To investigate the conservation of the determined epitopes NEP-D4 and NEP-D6 among different classical and presently circulating PEDV strains, 21 representative strains from GenBank and one strain isolated in our laboratory, HLJ/2011, were selected for sequence alignment using DNASTAR. The result showed that the sequence similarities of NEP-D4 and NEP-D6 among different PEDV strains were 98.3--100% and 81.8--100%, respectively, indicating that NEP-D4 and NEP-D6 were conserved. However, three conspicuous amino acid substitutions, including Asn^123^ to Lys in NEP-D4 and Arg^252^ to Lys and Ser^255^ to Asn in NEP-D6, were observed in several particular strains ([Fig. 4a](#f4){ref-type="fig"}).

To further test whether these mutations changed the antibody-antigen interactions, we used MAbs PN-D4 and PN-D6 to detect the PEDV strain HLJ/2011 by IFA. HLJ/2011 contains all of these mutations and can be stably passaged in Vero cells. The results revealed that HLJ/2011 could be recognized by both PN-D4 and PN-D6 ([Fig. 3g and h](#f3){ref-type="fig"}), suggesting these three substitutions do not alter the antigenicity of epitopes NEP-D4 and NEP-D6 and that both NEP-D4 and NEP-D6 are highly conserved. In addition, sequence alignment among all the known members within subfamily *Coronavirinae* revealed that epitope NEP-D4 and NEP-D6 are highly specific to PEDV ([Fig. 4b](#f4){ref-type="fig"}) because the homology of these two regions between PEDV and all other members of *Coronavirinae* remains very low (\<44%).

Cross-reactivity analysis
-------------------------

To investigate whether PEDV cross-reacts with TGEV on the epitopes NEP-D4 and NEP-D6, we performed IFA against the TGEV strain SH/2012 using MAbs PN-D4 or PN-D6 as the primary antibody. No fluorescent signals were observed ([Fig. 3j and k](#f3){ref-type="fig"}). Moreover, in Western blotting assays, no bands appeared to indicate the interaction of TGEV hyperimmune antisera and the epitope NEP-D4 and NEP-D6 ([Fig. 3e](#f3){ref-type="fig"}). These results suggested that the epitopes NEP-D4 and NEP-D6 could not cause cross-reactivity between PEDV and TGEV.

Intrinsically disordered regions on epitope NEP-D4
--------------------------------------------------

To better understand the effect of NEP-D4 in combination with PN-D4, we used multiple online tools to compute the physical and chemical parameters of NEP-D4. One of these tools, the GeneSilico MetaDisorder server, was used to predict the intrinsic disorder. Three regions presented with the highest propensity for intrinsic disorder, which we designated as PIDR[@b18][@b19][@b20][@b21][@b22], PIDR^107--116^ and PIDR^127--133^ ([Fig. 5a](#f5){ref-type="fig"}). The prediction suggested that there might be some intrinsically disordered regions on NEP-D4. To verify this prediction, purified GST-tagged NEP-D4 was treated with trypsin and used for detection against PN-D4 or anti-GST antibody by Western blotting. We observed that the trypsin-treated peptide was recognized by anti-GST antibody but not by MAb PN-D4 ([Fig. 5b](#f5){ref-type="fig"}). In addition, we repeated the experiment with the freeze-thaw cycle-treated GST-tagged NEP-D4. The result showed that the treated peptide (up to 5 and 10 cycles) could be recognized by MAb PN-D4 but not by the anti-GST antibody ([Fig. 5c](#f5){ref-type="fig"}). The intrinsically disordered proteins have a high proportion of solvent-exposed residues, making them highly accessible to protease and resistant to cold treatment[@b65][@b66]. Taken together, these results suggested that NEP-D4 is likely to be an intrinsically disordered protein.

3D structure modeling of the epitopes
-------------------------------------

To clarify the spatial locations of NEP-D4 and NEP-D6 on N protein, we generated a 3-dimensional structural model of PEDV N protein using intensive modeling based on nine templates in the Phyre2 server. The prediction result showed that 251 of 441 residues (57%) were modeled at \>90% accuracy; the remaining 191 residues were modeled *ab initio*. The amino acids of NEP-D6 were located in close proximity and were exposed on the surface of the N protein, suggesting that NEP-D6 is highly likely to be a linear epitope. By contrast, NEP-D4 is much more complex; although most of the amino acids are located on the surface, a small fraction of its residues are buried inside the N protein, suggesting that NEP-D4 is more likely to be a conformational epitope ([Fig. 6](#f6){ref-type="fig"}).

Discussion
==========

As one of the most serious intestinal infectious diseases, PED has posed a substantial threat to the swine industry of many countries over the last few years[@b12][@b16][@b67]. The accurate diagnosis at the early stage of infection plays a key role in PEDV prevention. The N protein of PEDV consists of 441 amino acids and represents an essential agent in the formation of the virus nucleocapsid structure. The abundant expression of N protein in PEDV-infected cells and the high conservation among different PEDV strains make it fairly suitable for use as a target for PEDV diagnosis[@b30][@b68]. However, the epitopes on PEDV N protein have been poorly characterized. In the present study, six monoclonal antibodies were generated against PEDV from BALB/c mice immunized with the purified PEDV strain FJzz1/2011. Among these antibodies, MAbs PN-D4 and PN-D6 were demonstrated as N protein-specific; the remaining four MAbs are still being studied (data not shown). Combined with ELISA and Western blotting, peptide scanning was performed to identify the epitopes of MAbs PN-D4 and PN-D6. We confirmed that Leu[@b18] and Ile^133^ were the essential amino acids of the epitope NEP-D4 because the deletion of either of these amino acids stopped the recognition between NEP-D4 and PN-D4. Notably, the absorbance value also largely declined when the peptide was truncated at Leu[@b18] instead of Ser[@b17]. Therefore, Ser[@b17] might have a significant effect on the antigenicity of NEP-D4, although Leu[@b18] was the only essential amino acid at the N-terminus of this epitope. Likewise, Arg^252^ and Lys^262^ are crucial amino acids for the binding of epitope NEP-D6 with MAb PN-D6. The results suggested that NEP-D4 (residues 18--133) and NEP-D6 (residues 252--262) are the specific antigenic epitopes of MAbs PN-D4 and PN-D6, respectively.

The epitopes NEP-D4 and NEP-D6 steadily exist on different PEDV strains that are both classical and currently circulating ([Fig. 4a](#f4){ref-type="fig"}). Additionally, the sequence similarities of the epitopes NEP-D4 and NEP-D6 with the representative strains were 98.3--100% and 81.8--100%, respectively. Although three major mutations, Asn^123^ to Lys, Arg^252^ to Lys, and Ser^255^ to Asn, were observed in certain strains, these substitutions do not alter the antigenicity of NEP-D4 and NEP-D6 because PN-D4 and PN-D6 could precisely recognize another PEDV strain, HLJ/2011, which was isolated in our laboratory and contains all three of these mutations ([Fig. 3g](#f3){ref-type="fig"} and h). In addition, we demonstrated that NEP-D4 and NEP-D6 could be recognized by PEDV pig antisera collected at 14 and 21 days after inoculation with PEDV, indicating that PEDV infection could induce specific host antibodies against NEP-D4 and NEP-D6 ([Fig. 3c](#f3){ref-type="fig"} and d). These findings suggested that epitopes NEP-D4 and NEP-D6 were highly conserved and immunogenic; both MAbs PN-D4 and PN-D6 and epitopes NEP-D4 and NEP-D6 have the potential for use as effective tools in the serological diagnosis of PEDV during early stages of infection. Thus far, N protein and MAbs against N protein have been widely used for the diagnosis of PEDV. Hou *et al*. established an ELISA system using recombinant N protein generated in *Escherichia coli*[@b69]; Okda *et al*. established indirect ELISA and FMIA (Fluorescent microsphere immunoassay) based on recombinant N protein, and blocking ELISA based on N protein-specific MAbs[@b45].

Recently, a one-way cross-reactivity between PEDV strains and TGEV hyperimmune pig antisera was clearly observed, and one or more epitopes on the N-terminal region of N protein were hypothesized to be the root cause of this cross-reactivity[@b45]. Thus, the epitopes of N protein used for PEDV diagnosis should be highly PEDV-specific and the reported immunoassays above should be seriously re-examined. We analyzed the NEP-D4 and NEP-D6 epitope sequences of PEDV and other members within the subfamily *Coronavirinae*, especially TGEV, PRCV, and PDCoV, all of which can infect newborn piglets. We found that the amino acid sequences of NEP-D4 and NEP-D6 of PEDV differed greatly from their counterparts in other coronaviruses. NEP-D4 shared less than 43.1% homology with TGEV and PRCV of *Alphacoronavirus*, and only 26.5% homology with PDCoV of *Deltacoronavirus*. The homology of NEP-D6 between PEDV and the other three viruses (TGEV, PRCV, and PDCoV) remained at zero. We also used IFA to investigate whether NEP-D4 and NEP-D6 could induce cross-reactivity between PEDV and TGEV. The results showed that neither PN-D4 nor PN-D6 recognized TGEV, and the TGEV SH/2012 hyperimmune pig antisera failed to react with NEP-D4 and NEP-D6; these results indicated that NEP-D4 and NEP-D6 were unable to cause a cross-reaction between PEDV and TGEV. Therefore, the MAbs PN-D4 and PN-D6 and their corresponding epitopes NEP-D4 and NEP-D6 have the potential for use in developing an immunoassay that differentiates between PEDV and TGEV.

The epitope NEP-D6 has 11 amino acids and can be recognized by PN-D6 using Western blotting, a method that imposes protein denaturation. This finding indicates that NEP-D6 is a linear epitope, which agreed with the result that NEP-D6 is located on the surface of the predicted 3D structure of N protein ([Fig. 6a](#f6){ref-type="fig"} and b). However, the epitope NEP-D4 seems much more complicated. Western blotting suggested that NEP-D4 is a linear epitope, which contradicts the previous assumption that the full 116 aa length is too large to be a linear epitope when bound to an antibody. Again, multiple residues are buried inside N protein, and there is a significant spatial distance between the first residue (Leu[@b18]) and last residue (Glu^133^) of NEP-D4 ([Fig. 6d,e](#f6){ref-type="fig"} and f). The NEP-D4 portion of the 3D model is highly reliable because the residues 18--133 were constructed based on five templates (PDB IDs: c3hd4A, d2bxxa1, d2geca1, d1sska and c4ud1B) at nearly 100% confidence, as shown in [Fig. 6h](#f6){ref-type="fig"}. Therefore, NEP-D4 is more likely to be a conformational epitope than a linear epitope. Interestingly, a denatured conformational epitope is unexpectedly recognized by its cognate antibody in Western blotting. Although it is possible that the formation of some disulfide bridges between certain residues may have contributed to this binding effect, this possibility was ruled out by the ability of PN-D4 to react with dithiothreitol (DTT)-treated NEP-D4 in a Western blotting assay ([Fig. 5d](#f5){ref-type="fig"}). Additionally, no disulfide bridges were predicted by the online software PredictProtein (data not shown). We also analyzed the other properties of NEP-D4. The software GeneSilico metadisorder predicted that NEP-D4 is an intrinsically disordered protein, which was further confirmed by two independent experiments: namely, trypsin-treated NEP-D4 could not react with PN-D4, and NEP-D4 underwent freeze-thaw cycles (up to 5 and 10 times) that were indeed recognized by PN-D4, albeit weakly. As previous findings have shown, the solvent-exposed residues on IDPs make proteins highly susceptible to protease; moreover, IDPs have much higher cold stability than structured proteins[@b65][@b66]. Thus, we speculated that folding occurred upon binding, which may have led to the recognition of NEP-D4 by PN-D4. Specifically, when the antibody binds to the first or last residue of the epitope NEP-D4, it may trigger the disordered domain to fold completely to form a certain conformational site, which could, in turn, be recognized by MAb PN-D4. In a previous study, different PEDV and TGEV pig antisera were used in a two-way cross-reactivity examination of different PEDV and TGEV strains, but only a one-way reactivity between TGEV Miller hyperimmune pig antisera and PEDV strains was observed. The complex mechanism remains unclear[@b47]. However, given that the N-terminal region of the N protein is intrinsically disordered, some disordered epitopes such as NEP-D4, which may be folded under certain conditions, might be the cause of the one-cross reactivity between PEDV and TGEV. In other words, the antibodies generated from PEDF infection cannot induce the folding of the disordered epitope on TGEV, whereas the corresponding epitope on PEDV can fold upon the binding of the antibodies produced from the infection of certain TGEV strains with specific epitopes. These hypotheses merit further investigation.

In conclusion, we first identified two highly conserved and specific epitopes on the N protein of PEDV. While NEP-D6 (residues 252--262) is a linear epitope, NEP-D4 (residues 18--133) is an intrinsically disordered epitope. The recognition between NEP-D4 and its cognate antibody might require folding effects upon antibody binding. Most importantly, epitopes NEP-D4 and NEP-D6 and MAbs PN-D4 and PN-D6 could be used as very effective tools in diagnosing PEDV, even at very early stages of PEDV infection.

Methods
=======

Ethics Statement
----------------

All animal care and procedures were performed in strict accordance with the guidelines and regulations of the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) under the permit number of SYXK-2011-0116. All experiments underwent scrutiny and approval by the Animal Care and Use Committee at the Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China.

Virus strains, cell lines and antisera
--------------------------------------

The currently circulating PEDV strain FJzz1/2011 and classical PEDV strain HLJ/2011 were isolated and passaged in Vero cell lines supplemented with 5 μg/ml trypsin (Sigma-Aldrich, St. Louis, MO, USA). Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Gibco, Carlsbad, CA, USA). The PEDV antisera were previously produced from pigs immunized with strain FJzz1/2011 and were preserved in our laboratory. The antisera used in this study were collected 1 day before and 14 and 21 days after immunization. In addition, the TGEV strain SH/2012, anti-TGEV N protein MAb and its hyperimmune antisera were obtained from SH/2012-immunized pigs and preserved in our laboratory.

Development of MAbs
-------------------

The PEDV strain FJzz1/2011 was purified and used as the antigen to immunize mice, and hybridomas secreting MAbs against PEDV were generated. To purify FJzz1/2011, 100 mL of virus suspension was collected and centrifuged at 5,000 × *g* for 30 min, 8,000 × *g* for 30 min, and 12,000 × *g* for 30 min to eliminate macromolecules. The supernatant was transferred to a new tube for ultracentrifugation at 30,000 × *g* for 1 h. The precipitate was resuspended in 1 mL of phosphate-buffered saline (PBS), followed by sucrose gradient centrifugation at 31,000 × *g* for 3 h. The purified PEDV suspension was mixed 1:1 with Freund's complete adjuvant. Next, five BALB/c mice were intraperitoneally (ip) injected with the emulsified PEDV particles at a concentration of 50 μg per mouse. The interval between each injection was two weeks. After the third injection, spleen cells were removed and fused with SP20 cells to form hybridomas under aseptic conditions. The hybridomas were selectively cultured in HAT medium and HT medium. Finally, the positive hybridomas were screened by IFA, where the monolayers of Vero cells were inoculated with the PEDV strain FJzz1/2011 at a multiplicity of infection (MOI) of 0.01. Eighteen hours after infection, the cell lines were fixed with 80% ice-cold ethanol and were used for the selection of hybridomas that could steadily secrete MAbs against PEDV. The purified stable monoclonal hybridomas were then injected into the peritoneal cavity of mice to produce ascites fluid.

Production of recombinant PEDV N protein and N protein truncated constructs
---------------------------------------------------------------------------

The whole RNA of FJzz1/2011 was extracted and converted into complementary DNA (cDNA). The entire N gene of PEDV was amplified from the cDNA by PCR using primers ([Table 1](#t1){ref-type="table"}) containing BamH1 and Xho1 restriction enzyme sites. The following PCR steps were used: initial denaturation at 94 °C for 3 min, followed by 32 cycles of denaturation at 94 °C for 30 seconds, annealing at 56 °C for 30 seconds and elongation at 70 °C for 30 seconds, and a final extension at 70 °C for 10 min. The obtained N gene was processed by restriction endonucleases BamH1 and Xho1 and was cloned into the prokaryotic expression vector pGEX-6p-1. The recombinant plasmid was transformed into the *Escherichia coli* strain BL21 (Tiangen, Beijing, China) and was expressed at 37 °C for 5 h in the presence of 1 mM isopropyl β-D-thiogalactoside (IPTG) (Sigma-Aldrich, St. Louis, MO, USA). The recombinant PEDV N protein was obtained and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Using the same method, we obtained a series of recombinant GST fusion N protein-truncated constructs, including GST-N1, GST-N2, GST-N1-1-GST-N1-11, and GST-N2-1-GST-N2-11.

ELISA
-----

The GST fusion N protein was coated onto ELISA plates (Thermo Fisher Scientific, Waltham, MA, USA) at 0.5 μg/well, followed by overnight incubation at 4 °C. The ELISA plates were blocked with 5% skimmed milk in PBST (PBS plus 0.5% Tween 20) at 37 °C for 2 h. Thereafter, the plates were washed three times with PBST, and ascites fluids raised against PEDV were added as primary antibodies to each well at a dilution of 1:200 at 37 °C for 1 h. The plates were washed again with PBST three times, and HRP conjugated goat anti-mouse IgG H&L (1/10,000 dilution) (Jackson ImmunoResearch, West Grove, PA, USA) was added as a secondary antibody at 37 °C for 1 h. The plates were washed with PBST five times, and 3,3′,5,5′-tetramethylbenzidine (TMB) substrate (Amresco, Cleveland, OH, USA) was added to each well for 10 min at room temperature. Finally, 2 M H~2~SO~4~ was added to the plates to stop the reaction, and the absorbance value of each well at 450 nm was read. To map the epitopes of N protein, all other GST fusion proteins (GST-N1, GST-N2, GST-N1-1-GST-N1-11, and GST-N2-1-GST-N2-11) were coated onto ELISA plates and were detected using the MAbs PN-D4 or PN-D6 as the primary antibodies using the same method above.

Western blotting
----------------

Western blotting was used to further confirm the minimal antigenic regions targeted by MAbs PN-D4 and PN-D6 and to test whether the identified epitopes on N protein caused the cross-reactivity between PEDV and TGEV. The expressed N protein-truncated constructs were separated by SDS-PAGE on 12% gels and were transferred onto nitrocellulose (NC) membranes. After blocking with 5% skimmed milk for 2 h at room temperature, the membranes were exposed to primary antibodies for 1 h at room temperature. The primary antibodies used in the epitope mapping were MAbs PN-D4 and PN-D6, which were diluted 1:500 (0.5 μg/ml). The PEDV pig antisera and TGEV pig antisera were diluted 1:2000 to be used as the primary antibodies to detect the cross-reactivity between PEDV and TGEV. After unbound primary antibodies were rinsed, the membranes were immersed into the HRP conjugated goat anti-mouse IgG H&L or goat anti-pig IgG H&L and incubated for 30 min at room temperature. Additionally, the positive GST fusion proteins on the membranes were detected by chemiluminescence.

IFA
---

IFA was performed to screen for MAbs specific to the PEDV strain FJzz1/2011 and to detect whether MAbs PN-D4 and PN-D6 could recognize the PEDV strain HLJ/2011 and TGEV strain SH/2012. Monolayers of Vero cells inoculated with FJzz1/2011 or HLJ/2011 at a MOI of 0.01 or monolayers of ST cells inoculated with TGEV strain SH/2012 at a MOI of 0.01 were incubated at 37 °C. Twelve hours later, the cell lines were gently rinsed and fixed with 80% ice-cold ethanol overnight at 4 °C. MAbs PN-D4 and PN-D6 (1:200) were added to the cells as primary antibodies for 1 h at 37 °C. The cells were then rinsed with PBS three times, and fluorescein (FITC)-conjugated donkey anti-mouse IgG (H + L) antibody (Life Technologies, Carlsbad, CA, USA) diluted to 1:2000 was added to cells at 37 °C for 1 h. The cells were then rinsed three times with PBS and stained with 4′,6-diamidino-2-phenylindole (DAPI). After incubation at 37 °C for 5 min, the cells were rinsed five times and analyzed by epifluorescence microscopy.

Bioinformatics analysis
-----------------------

To further investigate the conservation and specificity of the identified epitopes, we selected another 22 PEDV representative strains ([Table 2](#t2){ref-type="table"}) and 32 representative coronavirus strains ([Table 3](#t3){ref-type="table"}) within the subfamily *Coronavirinae* for multiple sequence alignment using MegAlign Clustal W method in DNASTAR Lasergene software.

Software prediction
-------------------

A few online tools were used to characterize the determined epitopes. The GeneSilico MetaDisorder server (<http://iimcb.genesilico.pl/metadisorder/>) was used to predict the presence of intrinsically disordered regions of epitope NEP-D4[@b70]. The Phyre2 server (<http://www.sbg.bio.ic.ac.uk/phyre2/>) was used to predict the 3D structure of PEDV N protein[@b71]. Nine templates in PDB were selected for construction by this program (c4ud1B, d2bxxa1, d1sska, d2geca1, c3hd4A, d2cjra1, d2ca1a1, d2ge7a1 and d2giba1). In addition, the PredictProtein server (<https://www.predictprotein.org>) was used to predict the disulfide bridges formed between amino acids.

Limited proteolysis and freeze-thaw cycle analyses
--------------------------------------------------

The recombinant protein GST-NEP-D4 was purified using Glutathione Sepharose 4B (GE Healthcare, Little Chalfont, UK), and the protein concentration was calculated by the absorbance at 280 nm (NanoDrop, Thermo Fisher Scientific, Waltham, MA, USA). Next, 10 μg of purified GST-NEP-D4 was removed and digested by 1 μg of trypsin (Sigma-Aldrich, St. Louis, MO, USA) in 100 mM KCl and 20 mM HEPES (pH 7.4 and 37 °C). The reaction was stopped by the addition of 1/6 volume of 6 × SDS loading buffer and heating to 100 °C for 5 min. Another 10 μg of purified GST-NEP-D4 was frozen at −80 °C for an hour, followed by thawing at room temperature. Finally, the samples treated with trypsin and freeze-thaw cycles were analyzed by Western blotting with MAb PN-D4 or an Anti-GST antibody, respectively, using the same methods described above.
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![Selection of MAbs against PEDV N protein.\
(**a**) Six MAbs were proven to be positive by IFA using PEDV inoculated cells. (**b**) The six positive clones were then tested by ELISA against GST-fusion N protein and GST-tag expressed in *Escherichia coli*.](srep39010-f1){#f1}

![Mapping of PEDV N protein epitopes.\
(**a**) Schematic diagram of the epitope mapping. The segments that could be recognized by both PN-D4 and PN-D6 are highlighted in red; the segments that could only be recognized by PN-D4 are highlighted in blue; the segments that could only be recognized by PN-D6 are highlighted in green; and the segments in gray are those that could not be recognized by either PN-D4 or PN-D6. According to (**a**), the N gene was divided into mutually overlapping N1 and N2 fragments and was directionally cloned into the pGEX-6p-1 vector. (**b**) Six hours after the addition of 1 mM IPTG, the induced products of GST-N, GST-N1 and GST-N2 were processed and analyzed using SDS-PAGE (12% separating gel and 5% stacking gel). (**c**) Next, the GST fusion proteins GST-N, GST-N1 and GST-N2 were coated onto ELISA plates (0.5 μg/well) and were probed with MAbs PN-D4 and PN-D6. After the first round of identification, N1 and N2 were further divided and expressed in two series of fusion proteins, GST-N1-1-GST-N1-11 and GST-N2-1-GST-N2-11 (**d**,**h**), which were analyzed by Western blotting and ELISA using PN-D4 (**e**,**g**), PN-D6 (**i**,**k**), and anti-GST Tag antibody (**f**,**j**), respectively.](srep39010-f2){#f2}

![The reactivity between epitopes and MAbs or antisera.\
The two fusion-expressed epitopes (GST-NEP-D4 and GST-NEP-D6) and the negative control (GST tag) were processed and analyzed by Western blotting using PN-D4, PN-D6, or pig PEDV antisera obtained at 14 and 21 days after starting the immunization. Pig TGEV hyperimmune antisera was used as the primary antibodies in membranes **a**,**b**,**c**,**d** and **e**. (**f**) We used the pig TGEV hyperimmune antisera to test GST-TGEV-N protein and GST tag. In IFA, monolayers of Vero cells inoculated with the PEDV strain HLJ/2011 or FJzz1/2011 and ST cells inoculated with the TGEV strain SH/2012 were fixed for IFA against MAbs PN-D4, PN-D6 or anti-TGEV N protein. (**g**) The PEDV strain HLJ/2011 was detected by MAb PN-D4. (**h**) The PEDV strain HLJ/2011 was detected by MAb PN-D6. (**j**) The TGEV strain SH/2012 was detected by MAb PN-D4. (**k**) The TGEV strain SH/2012 was detected by MAb PN-D6. (**i**) The PEDV strain FJzz1/2011 was detected by the MAb anti-TGEV N protein. (**l**) the TGEV strain SH/2012 was detected by the anti-TGEV N protein.](srep39010-f3){#f3}

![Amino acid sequence analysis of the two identified epitopes among different virus strains.\
(**a**) Amino acid sequence alignments of NEP-D4 and NEP-D6 from 23 PEDV representative strains, including 4 classical strains and 19 currently circulating strains. (**b**) Similarly, residues 18--133 and residues 252--262 of 21 *Alphacoronavirus* strains, including seven PEDV strains, six TGEV strains, two human coronavirus 229E strains, two human coronavirus NL63 strains, two PRCV (porcine respiratory coronavirus) strains and two FIPV (feline infectious peritonitis virus) strains, 6 *Betacoronavirus* strains, including two SARS-CoV (severe acute respiratory syndrome coronavirus) strains, two MERS-CoV (Middle East respiratory syndrome coronavirus) strains and two MHV (mouse hepatitis virus) strains, 2 IBV (Infectious bronchitis virus) strains from *Gammacoronavirus*, and 3 PDCoV (porcine deltacoronavirus) strains from *Deltacoronavirus*, were selected for alignment. The corresponding antigenic positions of NEP-D4 and NEP-D6 of all strains are colored green and red, respectively. PEDV strains FJzz1/2011 and HLJ/2011 isolated from our laboratory were marked with black triangles. The major mutations are highlighted by dotted frames.](srep39010-f4){#f4}

![Identification of IDRs and disulfide bridges in epitope NEP-D4.\
(**a**) The disorder plot for epitope EP4 was predicted by GeneSilico metadisorder. The x-axis shows the residues from 18 to 133, and the y-axis shows the disordered tendency ranging from 0 to 1. All residues with a disorder probability of more than 0.5 were considered to be disordered. The residues with plotted lines in the light blue region were predicted to be disordered; their counterparts in the bluish white area were considered ordered. (**b**) Four GST-NEP-D4 samples were treated with Trypsin under the same conditions, and the reactions were stopped at 0 min, 1 min, 5 min and 15 min. Next, the samples were processed and analyzed by Western Blotting using anti-GST antibody and PN-D4 as the primary antibodies. (**c**) Similarly, four additional GST-NEP-D4 samples were treated with freeze (−80 °C) and thaw (room temperature) cycles, which were repeated up to 0, 1, 5 and 10, times, respectively. Next, these samples were analyzed by Western blotting using the same antibodies above. (**d**) To rule out the interference of disulfide bridges, the reduced (1 M DTT-treated) and non-reduced (non DTT-treated) GST-NEP-D4 were analyzed by Western blotting using PN-D4.](srep39010-f5){#f5}

![Predicted 3D structural model of N protein with Phyre2.\
The N protein 3D model was visualized using the PyMOL molecular graphics and modeling system and was viewed from the side (**a**) and top (**c**). The protein epitope domains identified in this study are highlighted in different colors. (**b**) The conformation of the epitope NEP-D6 is displayed with all residues indicated in the corresponding positions. (**d**) The secondary structure of epitope NEP-D4 is depicted, in which the predicted disordered regions are colored green and tertiary structures showing PIDR1[@b18][@b19][@b20][@b21][@b22], PIDR2^107--116^ and PIDR3^127--133^ are colored blue, magenta and red, respectively. (**e**,**f**) The putative spatial positions of critical residues, E^133^ and L^18^, which are represented by orange. (**g**) The sequence of N protein with alpha helixes, beta strands and PIDRs. (**h**) Template coverage used in the structure modeling.](srep39010-f6){#f6}

###### Primers designed to amplify the N gene and its truncations.

  Segments                                                                                 Sequences (5′-3′)                                                              Positions (Amino Acid)
  ---------- ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------
  N1-1                                           N1-1U                                     CGGGATCCATGGCTTCTGTCAGCTTTCAGG                                                         1--150
  N1-1L                             GCCCTCGAGCCTGCTACGTGAATTTGCACG                                                                                                       
  N1-2                                           N1-2U                                     CGGGATCCATGGCTTCTGTCAGCTTTCAGG                                                         1--140
  N1-2L                             GCCCTCGAGAGGTGTGTTAGGTTCAACAATC                                                                                                      
  N1-3                                           N1-3U                                     CGGGATCCATGGCTTCTGTCAGCTTTCAGG                                                         1--139
  N1-3L                             GCCCTCGAGTGTGTTAGGTTCAACAATCTC                                                                                                       
  N1-4                                           N1-4U                                     CGGGATCCATGGCTTCTGTCAGCTTTCAGG                                                         1--136
  N1-4L                             GCCCTCGAGTTCAACAATCTCAACTACGCT                                                                                                       
  N1-5                                           N1-5U                                     CGGGATCCATGGCTTCTGTCAGCTTTCAGG                                                         1--133
  N1-5L                              GCCCTCGAGCTCAACTACGCTGGGAAGC                                                                                                        
  N1-6                                           N1-6U                                     CGGGATCCGTGCCATTATCCCTCTAT                                                             1--130
  N1-6L                             GCCCTCGAGGCTGGGAAGCTGTTGAGAGAAA                                                                                                      
  N1-7                                           N1-7U                                     CGGGATCCGTGCCATTATCCCTCTAT                                                            14--133
  N1-7L                              GCCCTCGAGCTCAACTACGCTGGGAAGC                                                                                                        
  N1-8                                           N1-8U                                     CGGGATCCGTGCCATTATCCCTCTAT                                                            14--132
  N1-8L                              GCCCTCGAGAACTACGCTGGGAAGCTGT                                                                                                        
  N1-9                                           N1-9U                                     CGGGATCCTCCCTCTATGCCCCTCTT                                                            17--133
  N1-9L                              GCCCTCGAGCTCAACTACGCTGGGAAGC                                                                                                        
  N1-10                                         N1-10U                                     CGGGATCCCTCTATGCCCCTCTTAGGGT                                                          18--133
  N1-10L                             GCCCTCGAGCTCAACTACGCTGGGAAGC                                                                                                        
  N1-11                                         N1-11U                                     CGGGATCCTATGCCCCTCTTAGGGTTAC                                                          19--133
  N1-11L                             GCCCTCGAGCTCAACTACACTGGGGAGC                                                                                                        
  N2-1                                           N2-1U                                     CGGGATCCAAGCTTAAGCAACAGCAGA                                                           241--442
  N2-1L                             GCCCTCGAGTTAATTTCCTGTATCGAAGAT                                                                                                       
  N2-2                                           N2-2U                                     CGGGATCCAAGCTTAAGCAACAGCAGA                                                           241--341
  N2-2L                              GCCCTCGAG ACGAACAGCCACATTACC                                                                                                        
  N2-3                                           N2-3U                                     CGGGATCCAAGCTTAAGCAACAGCAGA                                                           241--308
  N2-3L                               GCCCTCGAGTTCCGCATCTCCAAAAT                                                                                                         
  N2-4                                           N2-4U                                     GATCCAAGCTTAAGCAACAGCAGAAGCCCAAACAGGAAAGGTCTGACAGCAGCGGCAAAAATACACCTAAGAAGC           241--263
  N2-4L       TCGAGCTTCTTAGGTGTATTTTTGCCGCTGCTGTCAGACCTTTCCTGTTTGGGCTTCTGCTGTTGCTTAAGCTTG                                                                                
  N2-5                                           N2-5U                                     GATCCCAACAGCAGAAGCCCAAACAGGAAAGGTCTGACAGCAGCGGCAAAAATACACCTAAGAAGC                    244--263
  N2-5L           TCGAGCTTCTTAGGTGTATTTTTGCCGCTGCTGTCAGACCTTTCCTGTTTGGGCTTCTGCTGTTGG                                                                                     
  N2-6                                           N2-6U                                     GATCCCAGGAAAGGTCTGACAGCAGCGGCAAAAATACACCTAAGAAGC                                      250--263
  N2-6L                    TCGAGCTTCTTAGGTGTATTTTTGCCGCTGCTGTCAGACCTTTCCTGG                                                                                              
  N2-7                                           N2-7U                                     GATCC CAGGAAAGGTCTGACAGCAGCGGCAAAAATACACCTAAGC                                        250--262
  N2-7L                     TCGAG CTTAGGTGTATTTTTGCCGCTGCTGTCAGACCTTTCCTGG                                                                                               
  N2-8                                           N2-8U                                     GATCCCAGGAAAGGTCTGACAGCAGCGGCAAAAATACACCTC                                            250--261
  N2-8L                       TCGAGAGGTGTATTTTTGCCGCTGCTGTCAGACCTTTCCTGG                                                                                                 
  N2-9                                           N2-9U                                     GATCC GAAAGGTCTGACAGCAGCGGCAAAAATACACCTAAGC                                           251--262
  N2-9L                       TCGAG CTTAGGTGTATTTTTGCCGCTGCTGTCAGACCTTTCG                                                                                                
  N2-10                                         N2-10U                                     GATCC AGGTCTGACAGCAGCGGCAAAAATACACCTAAGC                                              252--262
  N2-10L                       TCGAG CTTAGGTGTATTTTTGCCGCTGCTGTCAGACCTG                                                                                                  
  N2-11                                         N2-11U                                     GATCC TCTGACAGCAGCGGCAAAAATACACCTAAGC                                                 253--262
  N2-11L                         TCGAG CTTAGGTGTATTTTTGCCGCTGCTGTCAGAG                                                                                                   

###### PEDV strains used to align the sequences of NEP-D4 and NEP-D6.

  Strains                      Country   Collection Date   Accession Number   Lengths of N protein (Amino Acid)
  --------------------------- --------- ----------------- ------------------ -----------------------------------
  FJzz1/2011                    China         2011          Not submitted                    441
  ZJCZ4/2012                    China         2011             JX524137                      441
  BJ-2011-1                     China         2011             JN825712                      441
  CH-ZMDZY/11                   China         2011             KC196276                      441
  CHGD-01                       China         2011             JX261936                      441
  GD-B                          China         2012             JX088695                      441
  IA1                            USA          2013             KF468753                      441
  CH-YNKM-8                     China         2013             KF761675                      441
  ISU13-22038-IA-homogenate      USA          2013             KF650373                      441
  13-019349                      USA          2013             KF267450                      441
  MN                             USA          2013             KF468752                      441
  NPL-PEDv                       USA          2013             KJ778615                      441
  USA/Iowa/18984/2013            USA          2013             KF804028                      441
  OH851                          USA          2014             KJ399978                      441
  KNU-1305                      Korea         2014             KJ662670                      441
  KNU-1406-1                    Korea         2014             KM403155                      441
  K14JB01                       Korea         2014             KJ623926                      441
  KNU-141112-feces              Korea         2014             KR873431                      441
  KUIDL-PED-2014-001            Korea         2014             KJ588064                      441
  CV777                        Belgium        1978             AF353511                      441
  HLJ/2011                      China         2011          Not submitted                    441
  CH/S                          China         1986             JN547228                      441
  DR13                          Korea         1999             JQ023161                      441

###### Coronavirus strains used to align the sequences of NEP-D4 and NEP-D6.

  Strains                      Country      Collection Date   Accession Number   Lengths of N protein (Amino Acid)
  ------------------------- -------------- ----------------- ------------------ -----------------------------------
  TGEV-SH/2012                   USA             2012          Not submitted                    382
  TGEV-PUR46-MAD                 USA             2001             AJ271965                      382
  TGEV-Purdue                    USA             1952             DQ811789                      382
  TGEV-Miller-M6                 USA             2006             DQ811785                      382
  TGEV-KT2                      Korea            2012             JQ693059                      382
  TGEV-HX                       China            2012             KC962433                      382
  HCoV-229E-933-40               USA             1993             KF514433                      389
  HCoV-229E-0349             Netherlands         2010             JX503060                      389
  HCoV-NL63/DEN/2005/193         USA             2005             JQ765568                      377
  HCoV-NL63/DEN/2009/20          USA             2009             JQ765567                      377
  PRCV-ISU-1                     USA             2006             DQ811787                      382
  PRCV-OH7269                    USA             2014             KR270796                      382
  FIPV-DF-2                    Hungary           2012             JQ408981                      377
  FIPV-79-1146                   USA             1979             AY994055                      377
  SARS-MA-15                     USA             2006             DQ497008                      422
  SARS-TW1                      Taiwan           2003             AY291451                      422
  MERS-CoV-Riyadh_2\_2012    Saudi Arabia        2012             KF600652                      413
  MERS-England/3/2013             UK             2013             KM21027                       413
  MHV-A59                        USA             2004             AY700211                      454
  MHV-JHM                        USA             2013            AC_000192                      455
  IBV-Georgia                    USA             1998             GQ504722                      409
  IBV-Mass41                     USA             1985             FJ904723                      409
  PDCoV-Illinois121              USA             2014             KJ481931                      342
  PDCoV/USA/Ohio137              USA             2014             KJ601780                      342
  PDCoV/CHJXNI2                 China            2015             KR131621                      342
